Nephrogenic Diabetes Insipidus following an Off-Label Administration of Sevoflurane for Prolonged Sedation in a COVID-19 Patient and Possible Influence on Aquaporin-2 Renal Expression
During the recent COVID-19 pandemic, the rapidly progressive shortage of intravenous sedative drugs led numerous intensive care units to look for potential alternatives in patients requiring mechanical ventilation for severe acute respiratory distress syndrome (ARDS). Inhalational sedation using the...
Saved in:
| Main Authors: | Camie Dupuis, Arnaud Robert, Ludovic Gerard, Johann Morelle, Pierre-François Laterre, Philippe Hantson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Anesthesiology |
| Online Access: | http://dx.doi.org/10.1155/2022/3312306 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current treatment of hereditary nephrogenic diabetes insipidus in children
by: Jin-Soon Suh
Published: (2025-06-01) -
Central and nephrogenic diabetes insipidus: updates on diagnosis and management
by: Kathryn Flynn, et al.
Published: (2025-01-01) -
Severe lithium-induced nephrogenic diabetes insipidus: The diuresis paradox
by: G S Tatz, et al.
Published: (2025-04-01) -
Bartter Syndrome Type 1 Presenting as Nephrogenic Diabetes Insipidus
by: Gianluca Vergine, et al.
Published: (2018-01-01) -
Four Japanese Patients with Congenital Nephrogenic Diabetes Insipidus due to the AVPR2 Mutations
by: Noriko Namatame-Ohta, et al.
Published: (2018-01-01)